The field of cancer genetics is at an exciting juncture in which the tools for interrogating cancer genes, genomes and networks have progressed enormously. The overall goal of the Cancer Genomes and Networks program (CGN) is to create a fertile environment for research on genetic abnormalities causing, or consistently associating with, the induction and progression of neoplasia and its systemic effects, and then to apply insights from these studies to clinical and translational research and patient treatment. The program is organized into four themes: Cancer genomes and genome integrity. Cancer epigenomes and transcriptional networks, Cancer proteomes and protein signaling networks, and Cancer metabolomes and metabolic networks. The CGN program has 31 members from 11 academic departments with $18.5 Million of peer reviewed research grant funding (annual direct costs). Members of the CGN program published 814 programmatically aligned articles since 2007, 10% were the result of intra-programmatic collaborations, 14% were inter-programmatic. The Cancer Center adds value to CGN by providing shared resource facilities, human tissue samples, and pilot project grants for translational research. The CGN program adds value to the Cancer Center by developing new methods/ technologies for high throughput analyses of complex biological systems that in the long run will benefit the diagnosis and the treatment of cancer.

Public Health Relevance

There is growing optimism that knowledge of the genetic make-up of individual tumors will allow both a greater understanding of the development of cancer and more successful individualized treatment of cancer. The CGN program will contribute to this goal through its focus on state-of-the-art genetics and genomics methods and their application to cancer research and treatment

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Diego
La Jolla
United States
Zip Code
Sen, Supriya; Langiewicz, Magda; Jumaa, Hassan et al. (2015) Deletion of serine/arginine-rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice. Hepatology 61:171-83
Hoffmann, Hanne M; Tamrazian, Anika; Xie, Huimin et al. (2014) Heterozygous deletion of ventral anterior homeobox (vax1) causes subfertility in mice. Endocrinology 155:4043-53
Hartman, Lisa L R; Crawford, John R; Makale, Milan T et al. (2014) Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors. J Pediatr Hematol Oncol 36:451-7
Williams, Richard T; Barnhill, Lisa M; Kuo, Huan-Hsien et al. (2014) Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth. PLoS One 9:e88219
Huang, Carlos P; Fofana, Mariama; Chan, Jefferson et al. (2014) Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin. Metallomics 6:654-61
Paolini, Paul; Pick, Daniel; Lapira, Jennifer et al. (2014) Developmental and extracellular matrix-remodeling processes in rosiglitazone-exposed neonatal rat cardiomyocytes. Pharmacogenomics 15:759-74
Goellner, Eva M; Smith, Catherine E; Campbell, Christopher S et al. (2014) PCNA and Msh2-Msh6 activate an Mlh1-Pms1 endonuclease pathway required for Exo1-independent mismatch repair. Mol Cell 55:291-304
Glidewell-Kenney, Christine A; Trang, Crystal; Shao, Paul P et al. (2014) Neurokinin B induces c-fos transcription via protein kinase C and activation of serum response factor and Elk-1 in immortalized GnRH neurons. Endocrinology 155:3909-19
Jiang, P; Mukthavaram, R; Chao, Y et al. (2014) In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells. Br J Cancer 111:1562-71
Jacques, Bonnie E; Montgomery 4th, William H; Uribe, Phillip M et al. (2014) The role of Wnt/*-catenin signaling in proliferation and regeneration of the developing basilar papilla and lateral line. Dev Neurobiol 74:438-56

Showing the most recent 10 out of 359 publications